In Brief
Immunity induced by certain vaccines declines over time. By studying B cell responses to phycoerythrin, Pape et al. find that memory B cells can be shortlived when generated from precursors that experience unusually strong early signals through their un-mutated antigen receptors.
SUMMARY
Although immune memory often lasts for life, this is not the case for certain vaccines in some individuals. We sought a mechanism for this phenomenon by studying B cell responses to phycoerythrin (PE). PE immunization of mouse strains with Igh b immunoglobulin (Ig) variable heavy chain (V H ) genes elicited affinity-matured switched Ig memory B cells that declined with time, while the comparable population from an Igh a strain was numerically stable. Igh b strains had larger numbers of PE-specific naive B cells and generated smaller germinal center responses and larger numbers of IgM memory cells than the Igh a strain. The properties of PE-specific B cells in Igh b mice correlated with usage of a single V H that afforded high-affinity PE binding in its germline form. These results suggest that some individuals may be genetically predisposed to generate non-canonical memory B cell responses to certain antigens because of avid antigen binding via germline-encoded V H elements.
INTRODUCTION
Antigen-specific immune memory results from the activation of naive B cells. Usually, a naive B cell recognizes an epitope on an antigen using six complementarity determining regions (CDRs) of its immunoglobulin (Ig) heavy (H) and light (L) chain B cell receptor (BCR). Although germline-encoded CDR1 and CDR2 contribute, CDR3s composed of the joints between variable (V), diversity, and joining segments of the IgH and IgL chains are generally the most important determinants of antigen binding (Xu and Davis, 2000) . Antigen binding and signals from helper T cells cause rare naive B cells to proliferate and differentiate into short-lived antibody-secreting plasmablasts or germinal center cells, some of which switch their IgM constant region to IgG and acquire somatic mutations in the V region (McHeyzerWilliams and McHeyzer-Williams, 2005; Tangye and Tarlinton, 2009) . Cells that acquire mutations that improve antigen binding gain a survival advantage by outcompeting other B cells for T cell help and emerge from the germinal center reaction as plasma cells or memory cells (Victora and Nussenzweig, 2012) capable of generating rapid secondary responses (Dogan et al., 2009; McHeyzer-Williams et al., 2015; Pape et al., 2011; Yoshida et al., 2010) .
Memory B cells are generally very long lived. For example, murine memory B cells specific for nitrophenyl or hen egg lysozyme show no reduction in number over a lifetime (Jones et al., 2015; Weisel et al., 2016) and human memory B cells specific for the smallpox vaccine are numerically stable for 50 years (Crotty et al., 2003) . This rule, however, does not apply to all immune responses. Human B cells specific for a conserved epitope on the influenza hemagglutinin stem region decline dramatically over a 70-week period after booster vaccination (Wheatley et al., 2015) , while non-stem-specific memory B cells are stable. Memory cells specific for sheep red blood cells (Dogan et al., 2009) or malaria merozoite surface protein 1 (Krishnamurty et al., 2016) slowly decline in mice after immunization. Similarly, C57BL/6 (B6) mice immunized with the algal protein phycoerythrin (PE) produce unstable swIg memory cells that decline with a halflife of about 80 days (Pape et al., 2011) . Gitlin et al. (2016) showed that the decline of PE-specific swIg memory B cells is related to the acquisition of somatic mutations that confer polyreactivity to self-antigens. B6 mice also generate an unusually large population of PE-specific IgM memory cells, which is numerically stable for the life the mouse (Pape et al., 2011) .
These results suggest that certain features of memory B cells depend on the inducing antigen. Here, however, we show that the nature of the B cell repertoire, not an inherent property of the antigen itself, can influence memory B cell formation. We confirmed that although B6 or C.B-17 mice, which share a set of Ighv genes, generated large numbers of PE-specific IgM memory cells and unstable swIg memory B cells, BALB/c mice, which have a different set (Collins et al., 2015; Herzenberg and Herzenberg, 1974) , formed many fewer IgM memory cells and had stable swIg memory B cells. The memory B cell phenotypes observed in B6 and C.B-17 mice correlated with usage of BCRs containing a single V H segment that afforded germline-encoded high affinity for PE. These results suggest that B cells that bind antigen avidly with germline-encoded elements of the BCR undergo a different memory B cell program than B cells that bind in the conventional CDR3-dependent manner.
RESULTS

B6
Mice Have More PE-Specific B Cells than BALB/c Mice We investigated whether the tendency of B6 mice to produce IgM memory cells and unstable swIg memory B cells Pape et al., 2011) was shared by two different inbred strains of mice, BALB/c and C.B-17. BALB/c mice have different sets of Ighv genes than B6 mice, defined as the Igh a haplotype for BALB/c and Igh b for B6 mice (Collins et al., 2015; Herzenberg and Herzenberg, 1974 (Bosma and Bosma, 1974) ; thus, all non-Igh genes, including H2, Igl, and Igk, are the same as BALB/c mice.
We first assessed the pre-immune repertoires of PE-specific B cells in these strains using an antigen-based cell enrichment method (Pape et al., 2011; Schittek and Rajewsky, 1990; Taylor et al., 2012) . Spleen and lymph node cells from each mouse were mixed with PE and another antigen, allophycocyanin (APC), and then magnetic beads coated with PE and APC antibodies. The cell suspensions were passed over magnetized columns to enrich the PE-and APC-bound cells. The cells in the pre-and post-enriched samples were fixed, permeabilized, and stained with lineage-defining antibodies. B cells were identified as cells lacking non-B cell lineage markers and expressing Ig and B220 ( Figure 1A ). Although PE-and APC-specific B cells could be detected in the total B cell population in unenriched spleen and lymph node samples from BALB/c, B6, and C.B-17 mice, the fraction of these cells increased by about 100-fold in the enriched samples ( Figure 1B) . PE-and APC-specific B cells were not detected in MD4 transgenic mice (Goodnow et al., 1988) that contained only monoclonal B cells specific for hen egg lysozyme ( Figure 1B) . These results showed that antigen-based B cell enrichment is a sensitive and specific method for detection of the antigen-specific B cells from polyclonal repertoires.
Use of this method revealed differences between the PE-specific pre-immune B cell repertoires. As previously described (Pape et al., 2011) , B6 mice that were never exposed to PE or APC contained about 20,000 PE-specific and 4,000 APC-specific naive B cells ( Figure 1C ). In contrast, BALB/c mice had only about 1,400 PE-specific naive B cells but contained a similar number of APC-specific naive B cells as B6 mice ( Figure 1C ). C.B-17 mice contained about 20,000 PE-specific and 4,000 APC-specific naive B cells like B6 mice ( Figure 1C) Figure 2A Germinal center B cells and plasmablasts were then measured to assess the quality of the primary response generated in each strain. The GL-7 marker was used to identify germinal center cells and abundant intracellular Ig was used to identify plasmablasts. The frequency and total numbers of PE-specific plasmablast and germinal center cells differed between the Igh a and Igh b strains at the peak of the response on days 9-16. The PE-specific population in BALB/c (Igh a )
mice consisted of about 80% germinal center cells and 5% plasmablasts, while the population in B6 and C.B17 (Igh b ) mice consisted of about 45% germinal center cells and 10% plasmablasts ( Figure 2B ). BALB/c (Igh a ) mice made 30,000 PE-specific plasmablasts while B6 and C.B17 (Igh b ) mice generated 50,000 ( Figure 2C ). Despite a smaller number of naive precursors, BALB/c (Igh a ) mice generated 500,000
germinal center cells, which was more than the 250,000 produced by B6 and C. 
Igh a Mice Produce Fewer IgM Memory Cells and More
Stable swIg Memory Cells than Igh b Mice Analysis of PE-specific memory B cells revealed another difference between the strains. Memory cells were identified as GL-7 À intracellular Ig lo cells ( Figure 2B ) that expressed IgM and IgD or lacked these isotypes and thus must have expressed a switched isotype ( Figure 3A ). BALB/c (Igh a ) mice generated about 30,000 PE-specific IgM and swIg memory cells 36 days after immunization, which fell to about 10,000 cells in each population by day 100 (Figures 3A and 3B) . Both populations were then maintained at this number until day 400 (Figures 3A and 3B). As previously described Pape et al., 2011) , B6 mice (Igh b ) mice generated about 200,000 PE-specific IgM and 50,000 swIg memory cells 36 days after immunization, which fell to about 100,000 and 20,000 cells, respectively, by day 100 ( Figures 3A and 3B ). The IgM memory cells were maintained at 100,000 cells per mouse until day 400, while the swIg memory cells declined from 20,000 to 2,000 (Figures 3A and 3B) . The numbers of PE-specific IgM and swIg memory cells in C.B-17 mice were like those in B6 mice although the analysis of C.B-17 mice was carried out only until day 200 ( Figure 3B ). Together the results showed that large populations of IgM memory cells and declining swIg memory cells were features of mice containing the Igh b set of Ighv genes.
We then considered the possibility that the differences in the PE-specific B cell responses in Igh a and Igh b mice were due to differences in BCR binding to PE. We assessed Ighv gene usage of PE-specific B cells in the two strains as a first step toward testing this idea. Naive and memory PE-specific B cells were purified from BALB/c (Igh
mice and Ighv sequences were amplified using a common Figure 4A and Tables S2 and S3 ). This Ighv gene is not present in Igh a strains (Collins et al., 2015) and was used at a frequency of only 6% in the non-PE-specific B cells from naive B6 mice ( Figure 4A and Table S4 ). The most common Ighv genes present in the naive repertoire of PE-specific B cells in BALB/c Igh a mice were found at a frequency of only 7% (Figure 4A and Table S1 ). The IgM and IgG PE-specific memory B cell repertoires of B6 and C.B-17 Igh b mice were also dominated by Ighv1-81, whereas individual Ighv genes from the BALB/c memory cells were found at frequencies less than 10% (Figure 4B and Tables S5, S6 , S7, S8, S9, and S10 BCRs bound to a single epitope. We assessed this possibility by mixing an unlabeled Fab fragment from a V H 1-81-containing PE-specific monoclonal antibody (CL33) with PE prior to staining of spleen and lymph nodes cells and magnetic bead-based cell enrichment. The rationale was that CL33 would occlude a single epitope on PE and prevent any naive B cell with a BCR specific for that epitope from binding (Wheatley et al., 2015) . Addition of CL33 reduced the number of PE-binding B naive cells in B6 mice by about 90% but had no effect on APC-binding B cells ( Figures 5A and 5B). Only 9% of the naive B cells that bound PE in the presence of CL33 used V H 1-81, while 24% used V H 10-1 (Figure 5C and Table S11 ), which was used by only 3% of PE-specific B cells in the absence of CL33 (Table S2 ). Addition of CL33 reduced the number of BALB/c naive B cells that bound PE by about 75% ( Figure 5B ). These results suggest that almost all V H 1-81-containing PE-specific BCRs from B6 mice and most from BALB/c mice recognize a single or overlapping epitope(s). Figure 1D ). This contention was supported by the observation that the Igh b naive B cells that bound PE in the presence of CL33, which were greatly enriched for non-V H 1-81-expressing cells ( Figure 5C ), bound less PE per cell than the unblocked V H 1-81-dominated population ( Figure 5D ). On the contrary, Igh a naive B cells that bound PE in the presence of CL33 bound PE as well as the unblocked population ( Figure 5D ). These results indicate that V H 1-81-containing BCRs from Igh b mice bound to the CL33 epitope on PE with a higher average affinity than BCRs that bound to other epitopes on the protein.
Furthermore, even though many PE-specific BCRs from Igh a mice also bound to the CL33 epitope, these BCRs had the same low affinity as BCRs specific for other epitopes ( Figure 5D ). The hypothesis that V H 1-81 IgH chains accounted for the highaffinity PE binding exhibited by the population from Igh b mice ( Figure 1D ) was also tested using CL33 and three other PE-specific monoclonal antibodies: CL20 (V H 1-81), CL21 (V H 8-5), and CL30 (V H 1-26). The V H 1-81-containing monoclonal antibodies CL20 and CL33 bound PE with much higher affinity than the non-V H 1-81-containing ones ( Figure 5E ). Although the sample size was small, these results are consistent with V H 1-81 conferring higher-affinity binding to PE than other V H segments.
V H 1-81-Containing Antibodies Bind to PE Mainly with CDR-H2 We then analyzed the amino acid sequences of V H 1-81 chains from PE-specific BCRs to search for clues about how these receptors bind PE with high affinity. We initially focused on the third heavy-chain complementarity-determining regions (CDR-H3) formed by recombination of V, D, and J segments because these elements are normally the major determinants of antigen specificity (Xu and Davis, 2000) . The CDR-H3s from total non-PE binding naive B cells from B6 mice contained a normal distribution of amino acid lengths centering on 11 amino acids ( Figure 6A ) with approximately equal representation of all four J H segments (Figure 6B) . The CDR-H3s from PE-binding naive B cells from B6 or C.B-17 mice also contained a normal distribution of lengths, although centering on 12 amino acids, and were modestly enriched for the J H 2 segment ( Figures 6A and 6B) . Therefore, CDR-H3s from PE-binding V H 1-81 BCRs were not limited to a certain amino acid length or J H segment, indicating that CDR-H3 was not a major determinant of PE binding. In contrast, the CDR-H3s from PE-specific V H 10-1 BCRs were either 6 or 12 amino acids in length and preferentially used a single J H (J H 4) ( Figures 6A and 6B ) as expected for CDR-H3-dependent antigen-binding. These results suggest that unlike conventional IgH chains such as those containing V H 10-1, which derive much of their antigen binding energy from CDR-H3, V H 1-81 chains achieve high affinity through some other part of the protein.
The lack of evidence for antigen-driven selection of the CDRH3s in V H 1-81-containing BCRs prompted an analysis of the CDR-H1 and CDR-H2 elements. We determined whether these regions were targeted for somatic mutations as expected for domains involved in antigen binding. On the contrary, the V H 1-81 CDR-H1 and CDR-H2s expressed by PE-specific swIg memory B cells contained about the same low number of replacement mutations as the framework regions while the CDR-H1 and especially CDR-H2s of non-V H 1-81 Igs had many more mutations ( Figure 6C ). These results are consistent with the germline-encoded sequences of CDR-H1 and/or CDR-H2 of V H 1-81 conferring PE binding that could not be improved in the germinal center reaction.
This possibility was examined using the PE-binding monoclonal antibodies. The CL33 and CL20 antibodies bind PE with the identical affinity ( Figure 5E ) and both use V H 1-81 and fortuitously the same V k , V k 10-94 (V H 1-81-containing PE-specific antibodies use a diverse set of IgL chains) . The Igk chains differed by only one amino acid and the CDR-H1 and CDR-H2s by 3 of 16 amino acids with only one non-conservative difference ( Figure 6D ). In contrast, the CDRH3s differed by 11 of 13 amino acids. The fact that these antibodies bind PE with identical affinity and amino acid sequences except for markedly different CDR-H3s is consistent with V H 1-81 B A Tables S1, S2, S3, and S4 for naive and Tables S5,  S6 , S7, S8, S9, and S10 for memory for the sequence data from each sample.
CDR-H1 and/or CDR-H2 being more important for PE binding than CDR-H3.
Recombinant antibodies and variants containing swapped domains were then generated in 293T cells to assess the contributions of the individual CDRs to PE-binding ( Figures 7A and 7B ). CL33 was used as a representative V H 1-81-containing antibody and CL30 as a non-V H 1-81 (V H 1-26)-containing antibody. These antibodies also contain different Vk chains (Vk10-94 for CL33 and Vk8-27 for CL30) and may bind their epitopes in different ways. Nonetheless, replacement of the CL33 CDR-H3 with that of CL30, which differed at 10 of the 13 amino acid positions, had almost no effect on PE binding, while replacement with that of an ovalbumin-specific IgH, which differed at 12 of the 13 amino acid positions, reduced PE binding but did not destroy it. Thus, CL33 was remarkably tolerant to changes in its CDR-H3. In contrast, CL30 was intolerant to changes in its CDR-H3 as substitution of the CL33 CDR-H3 abolished CL30 binding to PE. PE binding by CL30 and CL33 was abolished by replacement of their CDR-H2s with those of the other antibody. These results suggested that the V H 1-81-containing CL33 antibody bound to PE with CDR-H2 and to lesser extent, CDR-H3, while a more conventional antibody, CL30, depended on both elements. Table S11 for the sequence data. (D) Relative PE affinities (calculated as in Figure 1D unstable swIg memory B cells is an inevitable consequence of high-affinity antigen binding by a germline-encoded BCR element. Nussenzweig and colleagues showed that the decline of PE-specific swIg memory B cells in B6 mice depends on somatic mutation and is associated with BCR mutations that confer reactivity for self-antigens such as DNA or insulin . Given our finding that cells with V H 1-81-containing BCRs dominate the PE-specific B cell repertoire in Igh b mice, it is reasonable to postulate that V H 1-81 has a conformation that is conducive to acquisition of somatic mutation-dependent self-reactivity and clonal deletion. More work must be done to confirm that this is the case and to determine whether this mechanism accounts for other examples of declining B cell memory. The fact that some antigen-specific swIg memory B cell populations are very stable (Crotty et al., 2003; Jones et al., 2015; Weisel et al., 2016) indicates that instability is not a property of all swIg memory B cells. However, it has been reported that sheep red cell-specific and malaria antigen-specific swIg memory cells in mice (Dogan et al., 2009; Krishnamurty et al., 2016) and pertussis toxin-specific swIg memory cells in humans (Stenger et al., 2010) decline over time. Another particularly relevant example has been reported for human B cells specific for a conserved epitope on the influenza hemagglutinin stem region (Wheatley et al., 2015) . These B cells utilize V H 1-69, depend primarily on a specific residue in the CDR-H2 for hemagglutinin binding and declined dramatically over a 70-week period after booster vaccination, while non-stem-specific memory B cells were stable. These results provide another case where a B cell population with CDR-H2-focused BCRs generate unstable swIg memory B cells. Thus, swIg memory B cell decline may be more common than previously appreciated.
DISCUSSION
The different PE-specific immune responses in Igh b but not Igh a mice are consistent with the effects of Ig polymorphism reported for other B cell repertoires. About 50% of the antibodies specific for the hapten p-azophenylarsonate in the A/J strain mice contain an idiotypic epitope that is not present in p-azophenylarsonate antibodies produced by other strains (Pawlak et al., 1973) , which is due to a polymorphic gene in the Igh locus (Siekevitz et al., 1982) . Likewise, the capacity of certain mouse strains to produce thyroid-stimulating hormone receptor antibodies maps to the Igh locus (Rapoport et al., 2010) . Several studies indicate that humoral responses can also vary in people depending on the germline-encoded V H segments that they express (Field et al., 2002; Raposo et al., 2014; Sakkas et al., 1987; Wheatley et al., 2015) . A case of a single germline-encoded V segment controlling immunity has been reported for the human B cell response to the Hemophilus influenza type B (Hib) capsule (Feeney et al., 1996) . Most people produce Hib capsule-specific antibodies that contain a single IgL chain containing a V segment encoded by the IGVKA2 gene. These antibodies bind with high affinity to the Hib capsule without somatic mutations. The importance of these antibodies is evidenced by the fact that some people have IGVKA2 genes that cannot undergo productive rearrangement and these individuals are at high risk for contracting Hib infection. Together, the evidence is consistent with the possibility that the naive Hib capsule-specific B cell population in humans (A) CDR3s were identified as described by IMGT (Lefranc et al., 2003) can be dominated by cells with BCRs that bind to Hib mainly with the germline-encoded region of one Vk chain. A similar concept applies to T cells, as work from Van Braeckel-Budimir et al. (2017) indicates that CD8 + T cells in a malaria epitope-specific population bind to their ligand with the germline-encoded region of one T cell antigen receptor beta chain. These results suggest that antigen receptors that depend heavily on germline-encoded elements for antigen binding are a general feature of the T and B cell pre-immune repertoires for certain epitopes.
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EXPERIMENT MODEL AND SUBJECT DETAILS
Mice were housed in a specific pathogen-free facility at the University of Minnesota, and experiments were conducted according to federal and institutional guidelines and with the approval of the University of Minnesota Institutional Animal Care and Use Committee. Six-to 12-week-old, male and female, age and sex-matched mice were used for all experiments. were purchased from Jackson Labs. Recombination-activating gene-deficient MD4 mice were bred in our facility using MD4 mice (C57BL/6-Tg(IghelMD4)4Ccg/J) (Goodnow et al., 1988) and Rag1 À/À mice (B6.129S7-Rag1tm1Mom/J) both purchased from Jackson Laboratories. Animals were injected subcutaneously in the base of the tail with 50 mL of CFA (Sigma) emulsion containing either 15 mg of APC and/or 15 mg PE (Prozyme). For adoptive transfer experiments, purified naive B cells were prepared from the spleen and lymph nodes of CD45.1 + congenic mice with a negative selection kit from Miltenyi, and 2 3 10 7 cells were injected intravenously into recipient mice.
Hybridomas and recombinant antibodies
The ClonaCell-HY kit was used to produce B cell hybridomas. Briefly, female B6 mice were immunized with PE as described above and then boosted two weeks later with an intravenous injection of PE. Four days later, the spleen cells were fused with SP2/0-Ag14 myeloma cells in the presence of polyethylene glycol and hybridomas were selected and cloned in methyl cellulose containing hypoxanthine-aminopterin-thymidine. Four monoclonal antibody-secreting hybridomas, CL20, CL21, CL30, and CL33 were identified by screening hybridoma supernatants for PE-binding using an enzyme-linked immunosorbent assay (ELISA). Recombinant versions of the CL30 and CL33 monoclonal antibodies were generated as described . The Ighv, Iglv, or Igkv genes from each hybridoma were isolated using a first PCR performed with mixtures of forward primers specific for the Ighv, Iglv, or Igkv leader regions and reverse primers specific for the Ighg constant region. The products of this PCR, were subjected to a second PCR with mixtures of forward primers specific for sequences from the 5 0 ends of the Ighv, Iglv, or Igkv genes and a nested reverse primer specific for the Ighg constant region. The DNA sequences of these products was determined and the results used to order gene blocks from IDT encoding the CL30 or CL33 IgH and Igk chains (with the exception that the sequence encoding the CDL33 CDR-H2 was changed from IYPKSGNT to IYPRSGNT) or recombinant versions with CDR-H2 or CDR-H3 replacements. The assembled gene blocks contained 16 base pair overlapping regions on both ends for In-Fusion cloning (Takara Bio) into the AgeI and SalI-linearized AbVec2.0-IGHG1 plasmid encoding the human Cg1 constant region (Addgene -80795) (Tiller et al., 2009) . For the Igk chains, two more codon-optimized gene blocks encoding the VJ segment of the respective chains of CL33 and CL30 were generated and cloned into the AgeI and BsiWI-linearized vector Abvec1.1-IGKC (Addgene -80796) (Tiller et al., 2009 ). The gene blocks used for generating the recombinant antibodies are shown in the Table S12 .
The expression vectors encoding the relevant IgH and Igk segments for each B cell were co-transfected into HEK293T cells, and the antibodies secreted into the culture supernatants were purified on protein G. Concentrations of human IgG in the purified supernatants were determined by sandwich ELISA. Briefly, 96-well plates were coated with 10 mg per ml goat anti-human IgG Fc gamma (Jackson Immunoresearch) in PBS and blocked with 1% BSA in PBS. Serial dilutions of each sample were added to the plates along with a purified human IgG standard. Plate-bound human Ig was detected by incubating the wells sequentially with biotin-conjugated anti-human Ig Fc gamma (eBioscience), streptavidin-conjugated horse radish peroxidase (Perkin Elmer), and ABTS Peroxidase Substrate (KPL).
PE-binding ELISAs were performed by coating of 96-well plates with 20 mg per ml PE in PBS and blocking with 1% BSA in PBS. Serial dilutions of the recombinant human IgG antibodies or purified mouse monoclonal antibodies starting at 10 mg per ml were added, and bound Ig was detected with biotin-conjugated anti-human Ig Fc gamma (eBioscience) and streptavidin-conjugated horse radish peroxidase (Perkin Elmer) or HRP-anti-mouse Ig heavy and light chain antibody (Thermo Scientific), followed by ABTS Peroxidase Substrate (KPL). In some cases, the titer at half-maximal OD 405 was calculated for each sample.
Cell enrichment
Explanted lymph nodes and spleens were minced in collagenase and EDTA as previously described (Itano et al., 2003) and then passed through fine mesh, washed, and suspended in 0.2 mL of culture supernatant containing 24G2 antibody (ATCC, Manassas) plus 1% rat serum (Sigma) to block Fc receptors. Each sample was incubated with 1 mg PE or APC for 30 minutes at 4 C, washed with sorter buffer (PBS containing 0.1% NaN 3 and 2% fetal bovine serum), and incubated with 25 ml anti-PE or anti-APC microbeads (Miltenyi) for 15 minutes at 4 C. Samples were then washed, suspended in 3 mL of sorter buffer, and passed over magnetized LS columns. The columns were washed 3 times to remove unlabeled cells. After the last wash, the columns were removed from the magnetic field, and bound cells were eluted in 5 mL of sorter buffer.
Flow Cytometry and Cell Counts
Antibodies used for flow cytometry were from eBioscience (San Diego) unless otherwise indicated. Cell suspensions were incubated with FITC-labeled CD79b (BioLegend), PercP-Cy5.5-labeled mouse IgM, Alexa Fluor 700-labeled CD38, eFluor 450-labeled GL-7, BV786-labeled mouse IgD, BUV395-labeled B220 (BD Biosciences) antibodies, and either APC-eFluor780-labeled CD90.2, F4/80, CD11c, and Gr-1 or BV711-labeled CD4 (BD Biosciences), CD8 (BD Biosciences), F4/80 (BioLegend), CD11c (BioLegend), and Gr-1(BioLegend) antibodies. In some samples a BV605-labeled CD45.1 antibody was also included. The cells were then fixed in Cytofix/Cytoperm (BD Biosciences), washed with Perm Buffer (TONBO) and incubated with AF350-labeled mouse IgH and IgL chain antibody (ThermoFisher). Fluorescent beads (Invitrogen) were used to calculate total numbers of live lymphocytes in spleen or lymph node suspensions. To obtain the total number of PE-or APC-binding cells in a sample, this value was multiplied by the frequency of cells binding either PE or APC. For naive mice, only the PE-or APC-enriched fractions were used to obtain the total number of cells, as the majority of antigen-binding cells are present in this fraction (Pape et al., 2011) . For day 6-50 after immunization, the number of antigen-binding cells in the fraction that flows through the enrichment columns was added to the numbers from the enriched fraction. Flow cytometry was performed on a 5-laser (355 nm, 405 nm, 488 nm, 561 nm, 640 nm) LSRFortessa (BD Biosciences) and analyzed with FlowJo software (Tree Star).
Ighv Sequencing
For sequencing of B cells from the naive repertoire, suspensions of spleen and lymph nodes from naive BALB/c, C.B-17, or B6 mice were stained with PE, eFluor 450-labeled B220, and APC-eFluor780-labeled CD90.2, F480, CD11c, and Gr-1 (non-B cell lineage) antibodies. For sequencing of memory B cell repertoires, spleen and lymph node cells from PE/CFA immunized BALB/c or B6 mice were stained with PE, BV650-labeled B220, AF700-labeled CD38, FITC-labeled GL-7 (BD Bioscience) and APC-eFluor780-labeled CD90.2, F480, CD11c, and Gr-1 (non-B cell lineage) antibodies. PE-binding cells were enriched with anti-PE microbeads as described above and non-B cell lineage negative, PE + , B220 + cells (for the naive repertoire) or non-B cell lineage negative, PE + , B220 + cells that were CD38 + , GL7-negative (for the memory repertoire) were sorted using a FACS Aria II (640, 405, 561 nm lasers) into sorter buffer and pelleted. For hybridoma sequencing, cells growing in log phase were washed in PBS and pelleted. The cell pellets were then frozen at À80 C. Cell pellets were lysed in trizol reagent (Invitrogen) and RNA was isolated by mixing the lysate 1:1 with 100% ethanol and applying the mixture to Zymo-Spin IIICG columns (Zymo Research). cDNA was generated using a First-strand cDNA synthesis kit (Invitrogen) per the manufacturers recommendation. Ighv alleles were amplified with Herculase II DNA polymerase (Agilent) using a common variable region primer msVHE (5 0 -GGGAATTCGAGGTGCAGCTGCAGGAGTCTGG-3 0 ) (Seidl et al., 1997) and specific constant chain primers IgM reverse (5 0 -GATACCCTGGATGACTTCAGTGTTG-3 0 ) or IgG reverse (5 0 -CACACCGCTGGACAGGG-3 0 ). PCR products were separated on a 1% agarose gel and the 500 base pair fragment was extracted (QIAGEN). Samples were cloned using the StrataClone PCR cloning kit (Agilent) and the resulting plasmids were sequenced. Variable regions were identified using IgBLAST software from the National Center for Biotechnology Information. Due to limited BALB/c Ighv sequence information, antibodies genes from BALB/c samples were identified as the closest homologous sequence found within either the B6 database or from previously identified BALB/c sequences (Collins et al., 2015) . CDR-H3 sequence identity was determined using IMGT sequence definitions (Lefranc et al., 2003) .
PE-blocking experiments using anti-PE monoclonal antibody
The CL33 anti-PE hybridoma was produced in house from PE/CFA-injected B6 mice, and subjected to Ighv sequencing (see above). This analysis showed that CL33 used V H 1-81, D H 1-1, and J H 3 to encode its IgG2b heavy chain. The Fab form of the antibody was prepared using a kit (Thermo Scientific). In epitope blocking experiments, PE enrichment was performed as described above except that the PE was mixed with a 20-fold molar excess of CL33 Fab in sorter buffer, or sorter buffer alone, for 20 minutes before addition to cell suspensions.
QUANTIFICATION AND STATISTICAL ANAYSIS
Prism software (Graphpad) was used to calculate p values were determined by an unpaired two-tailed Student's t test. Differences between groups were considered significant for p values % 0.05.
DATA AND SOFTWARE AVAILABILITY
All the Ighv gene nucleotide sequence data is deposited on Mendeley Data at https://doi.org/10.17632/bb7k3g6vbg.1.
